| Variables |
groups |
Mean of differences |
P-value |
| Raloxifene/experimental N=18 |
Placebo/control N=19 |
| HbA1C(mg/dL) |
7.9 ± 2.5 |
8.1 ± 1.8 |
0.15 |
0.84 |
| TG(mg/dL) |
208.5 ± 84.1 |
167.3 ± 67.5 |
41.2 |
0.13 |
| Chol(mg/dL) |
209.5 ± 51.7 |
188.1 ± 43.3 |
21.4 |
0.21 |
| HDL(mg/dL) |
41.1 ± 5.4 |
41.3 ± 1.7 |
0.2 |
0.86 |
| LDL(mg/dL) |
105.4 ± 44.6 |
111.3 ± 44.8 |
5.9 |
0.71 |
| ACR(μg/mg) |
844.8 ± 1622.9 |
347 ± 584.6 |
497.8 |
0.22 |
| ACR log |
2.4 ± 0.63 |
2.16 ± 0.53 |
0.24 |
0.22 |
| GFR(ml/min) |
68.2 ± 12.9 |
70.4 ± 22.9 |
1.8 |
0.78 |
P value< 0.05 is considered statistically significant
TG: Triglyceride; Chol: Cholesterol; HDL: High Density Lipoprotein; LDL: Low Density Lipoprotein; ACR: Albumin to Creatinin ratio; ACR log: Logarithm of ACR; GFR:
Glomerular Filtration Rate |
